These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19006613)

  • 21. Current concepts on the immunopathogenesis of inflammatory bowel disease.
    Vora P; Shih DQ; McGovern DP; Targan SR
    Front Biosci (Elite Ed); 2012 Jan; 4(4):1451-77. PubMed ID: 22201968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunopathogenesis of inflammatory bowel diseases].
    Neurath MF; Schürmann G
    Chirurg; 2000 Jan; 71(1):30-40. PubMed ID: 10662999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease.
    Ashton JJ; Latham K; Beattie RM; Ennis S
    Aliment Pharmacol Ther; 2019 Oct; 50(8):885-900. PubMed ID: 31518029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome.
    Shahini A; Shahini A
    J Cell Commun Signal; 2023 Mar; 17(1):55-74. PubMed ID: 36112307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.
    Fonseca-Camarillo G; Yamamoto-Furusho JK
    Inflamm Bowel Dis; 2015 Sep; 21(9):2188-93. PubMed ID: 26111210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms.
    Balding J; Livingstone WJ; Conroy J; Mynett-Johnson L; Weir DG; Mahmud N; Smith OP
    Mediators Inflamm; 2004 Jun; 13(3):181-7. PubMed ID: 15223609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of cytokines in the pathogenesis of inflammatory bowel disease.
    Papadakis KA; Targan SR
    Annu Rev Med; 2000; 51():289-98. PubMed ID: 10774465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases.
    Faustini F; Zoli A; Ferraccioli GF
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():1-9. PubMed ID: 19530505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of Autophagy-Related Genes in the Pathogenesis of Inflammatory Bowel Disease.
    Kim S; Eun HS; Jo EK
    Cells; 2019 Jan; 8(1):. PubMed ID: 30669622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis.
    Greuter T; Vavricka SR
    Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):307-317. PubMed ID: 30791773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunology in medical practice. XXVI. Immunogenetics of chronic inflammatory bowel diseases].
    Bouma G; Peña AS
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2414-20. PubMed ID: 10608975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.
    Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Hoffmann HJ; Andersen Nexø B; Sode J; Vogel U; Andersen V
    PLoS One; 2015; 10(12):e0145302. PubMed ID: 26698117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-23 in inflammatory bowel diseases and colon cancer.
    Neurath MF
    Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.
    Guan Q; Zhang J
    Mediators Inflamm; 2017; 2017():4810258. PubMed ID: 28420941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of autophagy in the pathogenesis of inflammatory bowel disease.
    Iida T; Onodera K; Nakase H
    World J Gastroenterol; 2017 Mar; 23(11):1944-1953. PubMed ID: 28373760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
    Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
    Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent understanding of IBD pathogenesis: implications for future therapies.
    Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W
    Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
    Uhlig HH
    Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.